Heuer Gregory G, Smith Michelle J, Elliott J Paul, Winn H Richard, LeRoux Peter D
Department of Neurosurgery, University of Pennsylvania, Philadelphia, Pennsylvania 19107, USA.
J Neurosurg. 2004 Sep;101(3):408-16. doi: 10.3171/jns.2004.101.3.0408.
Increased intracranial pressure (ICP) is well known to affect adversely patients with head injury. In contrast, the variables associated with ICP following aneurysmal subarachnoid hemorrhage (SAH) and their impact on outcome have been less intensely studied.
In this retrospective study the authors reviewed a prospective observational database cataloging the treatment details in 433 patients with SAH who had undergone surgical occlusion of an aneurysm as well as ICP monitoring. All 433 patients underwent postoperative ICP monitoring, whereas only 146 (33.7%) underwent both pre- and postoperative ICP monitoring. The mean maximal ICP was 24.9 +/- 17.3 mm Hg (mean +/- standard deviation). During their hospital stay, 234 patients (54%) had elevated ICP (> 20 mm Hg), including 136 of those (48.7%) with a good clinical grade (Hunt and Hess Grades I-III) and 98 (63.6%) of the 154 patients with a poor grade (Hunt and Hess Grades IV and V) on admission. An increased mean maximal ICP was associated with several admission variables: worse Hunt and Hess clinical grade (p < 0.0001), a lower Glasgow Coma Scale (GSC) motor score (p < 0.0001); worse SAH grade based on results of computerized tomography studies (p < 0.0001); intracerebral hemorrhage (p = 0.024); severity of intraventricular hemorrhage (p < 0.0001); and rebleeding (p = 0.0048). Both intraoperative cerebral swelling (p = 0.0017) and postoperative GCS score (p < 0.0001) were significantly associated with a raised ICP. Variables such as patient age, aneurysm size, symptomatic vasospasm, intraoperative aneurysm rupture, and secondary cerebral insults such as hypoxia were not associated with raised ICP. Increased ICP adversely affected outcome: 71.9% of patients with normal ICP demonstrated favorable 6-month outcomes postoperatively, whereas 63.5% of patients with ICP between 20 and 50 mm Hg and 33.3% with ICP greater than 50 mm Hg demonstrated favorable outcomes. Among 21 patients whose raised ICP did not respond to mannitol therapy, all experienced a poor outcome and 95.2% died. Among 145 patients whose elevated ICP responded to mannitol, 66.9% had a favorable outcome and only 20.7% were dead 6 months after surgery (p < 0.0001). According to results of multivariate analysis, however, ICP was not an independent outcome predictor (odds ratio 1.26, 95% confidence interval 0.28-5.68).
Increased ICP is common after SAH, even in patients with a good clinical grade. Elevated ICP post-SAH is associated with a worse patient outcome, particularly if ICP does not respond to treatment. This association, however, may depend more on the overall severity of the SAH than on ICP alone.
颅内压(ICP)升高对颅脑损伤患者有不良影响,这是众所周知的。相比之下,关于动脉瘤性蛛网膜下腔出血(SAH)后与ICP相关的变量及其对预后的影响,研究较少。
在这项回顾性研究中,作者回顾了一个前瞻性观察数据库,该数据库记录了433例接受动脉瘤手术夹闭及ICP监测的SAH患者的治疗细节。所有433例患者均接受了术后ICP监测,而只有146例(33.7%)接受了术前和术后ICP监测。平均最大ICP为24.9±17.3 mmHg(平均值±标准差)。在住院期间,234例患者(54%)出现ICP升高(>20 mmHg),其中136例(48.7%)入院时临床分级良好(Hunt和Hess分级I - III级),154例分级较差(Hunt和Hess分级IV和V级)的患者中有98例(63.6%)出现ICP升高。平均最大ICP升高与多个入院变量相关:Hunt和Hess临床分级较差(p<0.0001)、格拉斯哥昏迷量表(GSC)运动评分较低(p<0.0001);根据计算机断层扫描结果SAH分级较差(p<0.0001);脑出血(p = 0.024);脑室内出血严重程度(p<0.0001);以及再出血(p = 0.0048)。术中脑肿胀(p = 0.0017)和术后GCS评分(p<0.0001)均与ICP升高显著相关。患者年龄、动脉瘤大小、症状性血管痉挛、术中动脉瘤破裂以及缺氧等继发性脑损伤等变量与ICP升高无关。ICP升高对预后有不良影响:ICP正常的患者中有71.9%术后6个月预后良好,而ICP在20至50 mmHg之间的患者中有63.5%预后良好,ICP大于50 mmHg的患者中有33.3%预后良好。在21例ICP升高对甘露醇治疗无反应的患者中,所有患者预后均较差,95.2%死亡。在145例ICP升高对甘露醇有反应的患者中,66.9%预后良好,术后6个月仅有20.7%死亡(p<0.0001)。然而,根据多变量分析结果,ICP不是独立的预后预测指标(优势比1.26,95%置信区间0.28 - 5.68)。
SAH后ICP升高很常见,即使是临床分级良好的患者。SAH后ICP升高与患者预后较差相关,特别是如果ICP对治疗无反应。然而,这种关联可能更多地取决于SAH的总体严重程度,而不仅仅取决于ICP。